United States, 22nd Jul 2024, King NewsWire – K Pharmaceuticals is proud to announce the reintroduction of Aquoral Spray, a trusted solution for managing dry mouth symptoms. This innovative oral spray provides long-lasting moisture and relief, helping to maintain oral health and comfort. Ideal for individuals experiencing dry mouth due to medication, medical conditions, or other factors, Aquoral Spray is easy to use and offers quick, effective hydration for the oral cavity.
Aquoral Spray is especially beneficial for those suffering from xerostomia, commonly known as dry mouth. This condition can arise from a variety of causes, including cancer treatments, Sjögren’s syndrome, CPAP machine usage, and certain medications like antihistamines. K Pharmaceuticals aims to provide a reliable solution to alleviate these symptoms and improve the quality of life for affected individuals.
Key Features and Benefits of Aquoral Spray:
- Lipid-Based Formula: Unlike many water-based products on the market, Aquoral Spray features a lipid-based formula that forms a protective coating in the mouth, providing relief for up to six hours.
- Versatile Use: Aquoral Spray is discrete and portable to aid in effective relief for dry mouth. It can be easily administered for those that show symptoms of dry mouth causing difficulty swallowing and chewing.
- Enhanced Oral Comfort: By maintaining moisture in the oral cavity, Aquoral Spray helps reduce discomfort and improve overall oral health.
Targeted Relief for Specific Conditions:
- Cancer Treatment-Related Dry Mouth: Aquoral Spray offers many patients immediate relief for individuals experiencing dry mouth due to cancer treatments such as radiotherapy. For more information, visit Aquoral Spray Cancer.
- Sjögren’s Syndrome: Patients with Sjögren’s syndrome can often find effective relief with Aquoral Spray. Detailed information is available at Aquoral Spray Sjögrens.
- CPAP Machine Users: Aquoral Spray addresses dry mouth symptoms associated with CPAP machine usage, providing a more restful sleep. Learn more at Aquoral Spray CPAP.
- Medication-Induced Dry Mouth: Aquoral Spray helps to mitigate the side effect of dry mouth caused by antihistamines and other medications. For further details, visit Aquoral Spray Antihistamines.
“We are pleased to provide a new option for managing dry mouth associated with sleep apnea and CPAP machines,” said , CEO of K Pharmaceutical. “According to the National Council on Aging, there are an estimated 39 million Americans who struggle with sleep apnea, and many have their sleep continually interrupted due to the side effect of dry mouth. Aquoral forms a protective coating of the oral mucosa, which helps alleviate dry mouth symptoms, often resulting in longer-lasting and more restful sleep.”
Aquoral was initially marketed by Mission Pharmacal under the name Aquoral, then sub-licensed to 3M under the name Xerostomia Relief Spray. Due to patient demand, it has been reintroduced to the market by K Pharmaceuticals. Patients were distraught when it was discontinued because they had not found anything else that worked as well. Founded in 2022, K Pharmaceuticals is a privately held pharmaceutical company dedicated to making innovative medications more accessible to patients. Restoring market access to Aquoral, an undervalued dry mouth treatment with unique technology and significant patient benefits, is the perfect first product for K Pharmaceutical.
About K Pharmaceuticals:
Founded in 2022, K Pharmaceutical is driven by passionate individuals committed to elevating the discussion and treatment of dry mouth, especially for those with moderate to severe dry mouth that significantly impacts their quality of life. The company’s mission is to restore market access to innovative treatments like Aquoral, providing patients with effective solutions for their health needs.
For more information about Aquoral Spray and its benefits, visit https://aquoralspray.com/.
Media Contact
Organization: K Pharmaceuticals
Contact Person: support team
Website: https://aquoralspray.com/
Email: Send Email
Country: United States
Release Id: 22072414584